CD274 and cancer: Therefore, immune checkpoint blockade therapy (ICBT) using monoclonal antibodies such as anti-PD-L1 and anti-PD-1 is effective in cancer treatment through the continuous activation of the body’s immune system and has recently been actively studied [5,6].